KIT mutations are common in testicular seminomas.

作者: Kathleen Kemmer , Christopher L. Corless , Jonathan A. Fletcher , Laura McGreevey , Andrea Haley

DOI: 10.1016/S0002-9440(10)63120-3

关键词:

摘要: Expression of KIT tyrosine kinase is critical for normal germ cell development and observed in the majority seminomas. Activating mutations are common gastrointestinal stromal tumors mastocytosis. In this study we examined frequency spectrum 54 testicular seminomas, 1 ovarian dysgerminoma 37 non-seminomatous (NSGCT). Fourteen seminomas (25.9%) contained exon 17 point including D816V (6 cases), D816H (3 Y823D (2 single examples Y823C, N822K, T801I. No were found or NSGCTs. transient transfection assays, mutant isoforms D816V, D816H, Y823D, N822K constitutively phosphorylated absence natural ligand KIT, stem factor (SCF). contrast, activation T801I wild-type required SCF. Mutants inhibited by imatinib mesylate (Gleevec, previously STI571) whereas both resistant to mesylate. Biochemical evidence activation, as assessed phosphorylation association with phosphatidylinositol (PI) 3-kinase tumor lysates, was largely confined a genomic mutation. These findings suggest that activating may contribute tumorigenesis subset but not involved NSGCT.

参考文章(49)
Alessandro Beghini, Paolo Peterlongo, Carla B. Ripamonti, Lidia Larizza, Roberto Cairoli, Enrica Morra, Cristina Mecucci, C-kit mutations in core binding factor leukemias. Blood. ,vol. 95, pp. 726- 728 ,(2000) , 10.1182/BLOOD.V95.2.726
Peter Blume-Jensen, Tony Hunter, Oncogenic kinase signalling. Nature. ,vol. 411, pp. 355- 365 ,(2001) , 10.1038/35077225
Lars Rönnstrand, Michael D. Waterfield, Carl-Henrik Heldin, Ivan Gout, Peter Blume-Jensen, Modulation of Kit/stem cell factor receptor-induced signaling by protein kinase C. Journal of Biological Chemistry. ,vol. 269, pp. 21793- 21802 ,(1994) , 10.1016/S0021-9258(17)31874-4
R. S. K. Chaganti, Jane Houldsworth, Genetics and biology of adult human male germ cell tumors. Cancer Research. ,vol. 60, pp. 1475- 1482 ,(2000)
Zhi-Qiang Ning, Jin Li, Robert J. Arceci, Activating Mutations of c-Kit at Codon 816 Confer Drug Resistance in Human Leukemia Cells Leukemia & Lymphoma. ,vol. 41, pp. 513- 522 ,(2001) , 10.3109/10428190109060342
Carsten Bokemeyer, Markus A. Kuczyk, Theresa Dunn, J�rgen Serth, Kristin Hartmann, Jens Jonasson, Torsten Pietsch, Udo Jonas, Hans-Joachim Schmoll, Expression of stem-cell factor and its receptor c-kit protein in normal testicular tissue and malignant germ-cell tumours Journal of Cancer Research and Clinical Oncology. ,vol. 122, pp. 301- 306 ,(1996) , 10.1007/BF01261407
Louise Tatton, Gary M. Morley, Rajesh Chopra, Asim Khwaja, The Src-selective Kinase Inhibitor PP1 Also Inhibits Kit and Bcr-Abl Tyrosine Kinases Journal of Biological Chemistry. ,vol. 278, pp. 4847- 4853 ,(2003) , 10.1074/JBC.M209321200
Edwin N. Geissler, Martha Liao, J. David Brook, Francis H. Martin, Krisztina M. Zsebo, David E. Housman, Stephen J. Galli, Stem cell factor (SCF), a novel hematopoietic growth factor and ligand for c-kit tyrosine kinase receptor, maps on human chromosome 12 between 12q14.3 and 12qter. Somatic Cell and Molecular Genetics. ,vol. 17, pp. 207- 214 ,(1991) , 10.1007/BF01232978
Alessandro Beghini, Ivana Magnani, Carla B Ripamonti, Lidia Larizza, Amplification of a novel c-Kit activating mutation Asn(822)-Lys in the Kasumi-1 cell line: a t(8;21)-Kit mutant model for acute myeloid leukemia. Hematology Journal. ,vol. 3, pp. 157- 163 ,(2002) , 10.1038/SJ.THJ.6200168